US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

6.66 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-993-86 D-1432-2016
Class II · Moderate risk Terminated

5 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-197-20 D-1431-2016
Class II · Moderate risk Terminated

5 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-233-54 D-1430-2016
Class II · Moderate risk Terminated

5 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-477-50 D-1429-2016
Class II · Moderate risk Terminated

5 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-483-61 D-1428-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-200-52 D-1427-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-140-20 D-1426-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-257-20 D-1425-206
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-287-50 D-1424-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-135-48 D-1423-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.05% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-256-50 D-1422-2016
Class II · Moderate risk Terminated

5 mcg/mL Fentanyl Citrate and 0.04% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-809-48 D-1421-2016
Class II · Moderate risk Terminated

4 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-214-48 D-1420-2016
Class II · Moderate risk Terminated

4 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-983-48 D-1419-2016
Class II · Moderate risk Terminated

4 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-126-50 D-1418-2016
Class II · Moderate risk Terminated

3.5 mcg/mL Fentanyl Citrate and 0.0625%Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-470-30 D-1417-2016
Class II · Moderate risk Terminated

3 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-837-48 D-1416-2016
Class II · Moderate risk Terminated

3 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-239-50 D-1415-2016
Class II · Moderate risk Terminated

3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-180-52 D-1414-2016
Class II · Moderate risk Terminated

3 mcg/mL Fentanyl Citrate and 0.01% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-217-97 D-1413-2016
Class II · Moderate risk Terminated

20 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-947-48 D-1412-2016
Class II · Moderate risk Terminated

20 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-216-96 D-1411-2016
Class II · Moderate risk Terminated

20 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-494-61 D-1410-2016
Class II · Moderate risk Terminated

20 mcg/mL HYDROmorphone HCl and 0.06% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-620-12 D-1409-2016
Class II · Moderate risk Terminated

20 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-189-48 D-1408-2016